(Q38419290)

2 September 2017

Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma (English)

1 reference

2 September 2017

1 reference

1 reference

Xingjun Yao

1

1 reference

2 September 2017

Gang Zhao

2

1 reference

2 September 2017

Hongfa Yang

3

1 reference

2 September 2017

Xinyu Hong

4

1 reference

2 September 2017

Li Bie

5

1 reference

2 September 2017

Guojin Liu

6

1 reference

2 September 2017

7 November 2009

1 reference

Journal of Cancer Research and Clinical Oncology

2 September 2017

1 reference

2 September 2017

136

1 reference

2 September 2017

5

1 reference

2 September 2017

677-684

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-009-0706-1

2 September 2017

0 references

cites work

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

1 reference

12 December 2020

Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

1 reference

12 December 2020

Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1.

1 reference

12 December 2020

Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients

1 reference

12 December 2020

Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin.

1 reference

12 December 2020

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

1 reference

12 December 2020

Cancer statistics, 2006

1 reference

12 December 2020

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.

1 reference

12 December 2020

Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation

1 reference

12 December 2020

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

12 December 2020

Rapid increase in colorectal cancer rates in urban Shanghai, 1972-97, in relation to dietary changes.

1 reference

12 December 2020

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

1 reference

12 December 2020

Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner

1 reference

12 December 2020

Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.

1 reference

12 December 2020

Differential effects between amphoterin and advanced glycation end products on colon cancer cells

1 reference

12 December 2020

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

12 December 2020

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

1 reference

12 December 2020

Dual roles for HMGB1: DNA binding and cytokine

1 reference

12 December 2020

Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas

1 reference

12 December 2020

Biology of human colon cancer metastasis

1 reference

12 December 2020

Global gene expression profiles of human head and neck squamous carcinoma cell lines.

1 reference

12 December 2020

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

1 reference

12 December 2020

10.1007/S00432-009-0706-1

Identifiers

DOI

1 reference

2 September 2017

1 reference